Cargando…
COVID-19 Case Investigation and Contact Tracing in the US, 2020
IMPORTANCE: Contact tracing is a multistep process to limit SARS-CoV-2 transmission. Gaps in the process result in missed opportunities to prevent COVID-19. OBJECTIVE: To quantify proportions of cases and their contacts reached by public health authorities and the amount of time needed to reach them...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176334/ https://www.ncbi.nlm.nih.gov/pubmed/34081135 http://dx.doi.org/10.1001/jamanetworkopen.2021.15850 |
_version_ | 1783703240055980032 |
---|---|
author | Lash, R. Ryan Moonan, Patrick K. Byers, Brittany L. Bonacci, Robert A. Bonner, Kimberly E. Donahue, Matthew Donovan, Catherine V. Grome, Heather N. Janssen, Julia M. Magleby, Reed McLaughlin, Heather P. Miller, James S. Pratt, Caroline Q. Steinberg, Jonathan Varela, Kate Anschuetz, Greta L. Cieslak, Paul R. Fialkowski, Veronica Fleischauer, Aaron T. Goddard, Clay Johnson, Sara Jo Morris, Michelle Moses, Jill Newman, Allison Prinzing, Lauren Sulka, Alana C. Va, Puthiery Willis, Matthew Oeltmann, John E. |
author_facet | Lash, R. Ryan Moonan, Patrick K. Byers, Brittany L. Bonacci, Robert A. Bonner, Kimberly E. Donahue, Matthew Donovan, Catherine V. Grome, Heather N. Janssen, Julia M. Magleby, Reed McLaughlin, Heather P. Miller, James S. Pratt, Caroline Q. Steinberg, Jonathan Varela, Kate Anschuetz, Greta L. Cieslak, Paul R. Fialkowski, Veronica Fleischauer, Aaron T. Goddard, Clay Johnson, Sara Jo Morris, Michelle Moses, Jill Newman, Allison Prinzing, Lauren Sulka, Alana C. Va, Puthiery Willis, Matthew Oeltmann, John E. |
author_sort | Lash, R. Ryan |
collection | PubMed |
description | IMPORTANCE: Contact tracing is a multistep process to limit SARS-CoV-2 transmission. Gaps in the process result in missed opportunities to prevent COVID-19. OBJECTIVE: To quantify proportions of cases and their contacts reached by public health authorities and the amount of time needed to reach them and to compare the risk of a positive COVID-19 test result between contacts and the general public during 4-week assessment periods. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study took place at 13 health departments and 1 Indian Health Service Unit in 11 states and 1 tribal nation. Participants included all individuals with laboratory-confirmed COVID-19 and their named contacts. Local COVID-19 surveillance data were used to determine the numbers of persons reported to have laboratory-confirmed COVID-19 who were interviewed and named contacts between June and October 2020. MAIN OUTCOMES AND MEASURES: For contacts, the numbers who were identified, notified of their exposure, and agreed to monitoring were calculated. The median time from index case specimen collection to contact notification was calculated, as were numbers of named contacts subsequently notified of their exposure and monitored. The prevalence of a positive SARS-CoV-2 test among named and tested contacts was compared with that jurisdiction’s general population during the same 4 weeks. RESULTS: The total number of cases reported was 74 185. Of these, 43 931 (59%) were interviewed, and 24 705 (33%) named any contacts. Among the 74 839 named contacts, 53 314 (71%) were notified of their exposure, and 34 345 (46%) agreed to monitoring. A mean of 0.7 contacts were reached by telephone by public health authorities, and only 0.5 contacts per case were monitored. In general, health departments reporting large case counts during the assessment (≥5000) conducted smaller proportions of case interviews and contact notifications. In 9 locations, the median time from specimen collection to contact notification was 6 days or less. In 6 of 8 locations with population comparison data, positive test prevalence was higher among named contacts than the general population. CONCLUSIONS AND RELEVANCE: In this cross-sectional study of US local COVID-19 surveillance data, testing named contacts was a high-yield activity for case finding. However, this assessment suggests that contact tracing had suboptimal impact on SARS-CoV-2 transmission, largely because 2 of 3 cases were either not reached for interview or named no contacts when interviewed. These findings are relevant to decisions regarding the allocation of public health resources among the various prevention strategies and for the prioritization of case investigations and contact tracing efforts. |
format | Online Article Text |
id | pubmed-8176334 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Medical Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-81763342021-06-17 COVID-19 Case Investigation and Contact Tracing in the US, 2020 Lash, R. Ryan Moonan, Patrick K. Byers, Brittany L. Bonacci, Robert A. Bonner, Kimberly E. Donahue, Matthew Donovan, Catherine V. Grome, Heather N. Janssen, Julia M. Magleby, Reed McLaughlin, Heather P. Miller, James S. Pratt, Caroline Q. Steinberg, Jonathan Varela, Kate Anschuetz, Greta L. Cieslak, Paul R. Fialkowski, Veronica Fleischauer, Aaron T. Goddard, Clay Johnson, Sara Jo Morris, Michelle Moses, Jill Newman, Allison Prinzing, Lauren Sulka, Alana C. Va, Puthiery Willis, Matthew Oeltmann, John E. JAMA Netw Open Original Investigation IMPORTANCE: Contact tracing is a multistep process to limit SARS-CoV-2 transmission. Gaps in the process result in missed opportunities to prevent COVID-19. OBJECTIVE: To quantify proportions of cases and their contacts reached by public health authorities and the amount of time needed to reach them and to compare the risk of a positive COVID-19 test result between contacts and the general public during 4-week assessment periods. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study took place at 13 health departments and 1 Indian Health Service Unit in 11 states and 1 tribal nation. Participants included all individuals with laboratory-confirmed COVID-19 and their named contacts. Local COVID-19 surveillance data were used to determine the numbers of persons reported to have laboratory-confirmed COVID-19 who were interviewed and named contacts between June and October 2020. MAIN OUTCOMES AND MEASURES: For contacts, the numbers who were identified, notified of their exposure, and agreed to monitoring were calculated. The median time from index case specimen collection to contact notification was calculated, as were numbers of named contacts subsequently notified of their exposure and monitored. The prevalence of a positive SARS-CoV-2 test among named and tested contacts was compared with that jurisdiction’s general population during the same 4 weeks. RESULTS: The total number of cases reported was 74 185. Of these, 43 931 (59%) were interviewed, and 24 705 (33%) named any contacts. Among the 74 839 named contacts, 53 314 (71%) were notified of their exposure, and 34 345 (46%) agreed to monitoring. A mean of 0.7 contacts were reached by telephone by public health authorities, and only 0.5 contacts per case were monitored. In general, health departments reporting large case counts during the assessment (≥5000) conducted smaller proportions of case interviews and contact notifications. In 9 locations, the median time from specimen collection to contact notification was 6 days or less. In 6 of 8 locations with population comparison data, positive test prevalence was higher among named contacts than the general population. CONCLUSIONS AND RELEVANCE: In this cross-sectional study of US local COVID-19 surveillance data, testing named contacts was a high-yield activity for case finding. However, this assessment suggests that contact tracing had suboptimal impact on SARS-CoV-2 transmission, largely because 2 of 3 cases were either not reached for interview or named no contacts when interviewed. These findings are relevant to decisions regarding the allocation of public health resources among the various prevention strategies and for the prioritization of case investigations and contact tracing efforts. American Medical Association 2021-06-03 /pmc/articles/PMC8176334/ /pubmed/34081135 http://dx.doi.org/10.1001/jamanetworkopen.2021.15850 Text en Copyright 2021 Lash RR et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License. |
spellingShingle | Original Investigation Lash, R. Ryan Moonan, Patrick K. Byers, Brittany L. Bonacci, Robert A. Bonner, Kimberly E. Donahue, Matthew Donovan, Catherine V. Grome, Heather N. Janssen, Julia M. Magleby, Reed McLaughlin, Heather P. Miller, James S. Pratt, Caroline Q. Steinberg, Jonathan Varela, Kate Anschuetz, Greta L. Cieslak, Paul R. Fialkowski, Veronica Fleischauer, Aaron T. Goddard, Clay Johnson, Sara Jo Morris, Michelle Moses, Jill Newman, Allison Prinzing, Lauren Sulka, Alana C. Va, Puthiery Willis, Matthew Oeltmann, John E. COVID-19 Case Investigation and Contact Tracing in the US, 2020 |
title | COVID-19 Case Investigation and Contact Tracing in the US, 2020 |
title_full | COVID-19 Case Investigation and Contact Tracing in the US, 2020 |
title_fullStr | COVID-19 Case Investigation and Contact Tracing in the US, 2020 |
title_full_unstemmed | COVID-19 Case Investigation and Contact Tracing in the US, 2020 |
title_short | COVID-19 Case Investigation and Contact Tracing in the US, 2020 |
title_sort | covid-19 case investigation and contact tracing in the us, 2020 |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176334/ https://www.ncbi.nlm.nih.gov/pubmed/34081135 http://dx.doi.org/10.1001/jamanetworkopen.2021.15850 |
work_keys_str_mv | AT lashrryan covid19caseinvestigationandcontacttracingintheus2020 AT moonanpatrickk covid19caseinvestigationandcontacttracingintheus2020 AT byersbrittanyl covid19caseinvestigationandcontacttracingintheus2020 AT bonacciroberta covid19caseinvestigationandcontacttracingintheus2020 AT bonnerkimberlye covid19caseinvestigationandcontacttracingintheus2020 AT donahuematthew covid19caseinvestigationandcontacttracingintheus2020 AT donovancatherinev covid19caseinvestigationandcontacttracingintheus2020 AT gromeheathern covid19caseinvestigationandcontacttracingintheus2020 AT janssenjuliam covid19caseinvestigationandcontacttracingintheus2020 AT maglebyreed covid19caseinvestigationandcontacttracingintheus2020 AT mclaughlinheatherp covid19caseinvestigationandcontacttracingintheus2020 AT millerjamess covid19caseinvestigationandcontacttracingintheus2020 AT prattcarolineq covid19caseinvestigationandcontacttracingintheus2020 AT steinbergjonathan covid19caseinvestigationandcontacttracingintheus2020 AT varelakate covid19caseinvestigationandcontacttracingintheus2020 AT anschuetzgretal covid19caseinvestigationandcontacttracingintheus2020 AT cieslakpaulr covid19caseinvestigationandcontacttracingintheus2020 AT fialkowskiveronica covid19caseinvestigationandcontacttracingintheus2020 AT fleischaueraaront covid19caseinvestigationandcontacttracingintheus2020 AT goddardclay covid19caseinvestigationandcontacttracingintheus2020 AT johnsonsarajo covid19caseinvestigationandcontacttracingintheus2020 AT morrismichelle covid19caseinvestigationandcontacttracingintheus2020 AT mosesjill covid19caseinvestigationandcontacttracingintheus2020 AT newmanallison covid19caseinvestigationandcontacttracingintheus2020 AT prinzinglauren covid19caseinvestigationandcontacttracingintheus2020 AT sulkaalanac covid19caseinvestigationandcontacttracingintheus2020 AT vaputhiery covid19caseinvestigationandcontacttracingintheus2020 AT willismatthew covid19caseinvestigationandcontacttracingintheus2020 AT oeltmannjohne covid19caseinvestigationandcontacttracingintheus2020 |